ARTICLE | Company News
Aerocrine, Apieron deal
May 24, 2010 7:00 AM UTC
Aerocrine acquired fellow diagnostic company Apieron's business and IP assets in a Chapter 7 bankruptcy auction for an undisclosed sum. As a result, Apieron's litigation against Aerocrine in the U.S. and Germany will be dismissed, excluding Aerocrine's infringement claims in the U.S. alleging that Apieron's Insight eNO system infringed Aerocrine's patents covering its Niox Mino and Niox Flex tests. All three products measure exhaled nitric oxide in asthma patients' breath as a measure of airway inflammation. ...